These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 291750)

  • 21. Treatment of an intracerebral rat brain tumor with Corynebacterium parvum and radiation.
    Douple EB
    Natl Cancer Inst Monogr; 1977 Dec; 46():179-84. PubMed ID: 206836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage activation and increased resistance to infection in immunosuppressed mice treated with Corynebacterium parvum vaccine or pyran copolymer.
    Stinnett JD; Morris MJ; Alexander JW
    J Reticuloendothel Soc; 1979 May; 25(5):525-31. PubMed ID: 458782
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
    Cullen RT; Ghaffar A
    J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression of marrow B lymphocytes by administration of Corynebacterium parvum in mice.
    Jyonouchi H; Kincade PW; Good RA
    J Immunol; 1981 Dec; 127(6):2502-7. PubMed ID: 6457877
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.
    Ryning FW; Krahenbuhl JL; Remington JS
    Immunology; 1981 Apr; 42(4):513-9. PubMed ID: 7239556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the thermal response of animal tumors by Corynebacterium parvum.
    Urano M; Suit HD; Dunn P; Lansdale T; Sedlacek RS
    Cancer Res; 1979 Sep; 39(9):3454-7. PubMed ID: 476675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of C. parvum therapy on intratumoral macrophage subpopulations.
    McBride WH; Moore K
    Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M; Yamashita T; Suit HD; Gerweck LE
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B; Gebhardt M; Linta J; Saffer E
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract]   [Full Text] [Related]  

  • 32. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii.
    Luft BJ; Remington JS
    J Immunol; 1984 May; 132(5):2375-80. PubMed ID: 6715884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages.
    Okuno K; Hashimoto T; Qian JH; Tsuchida T; Fujiwara H; Hamaoka T
    Jpn J Clin Oncol; 1985 Mar; 15(1):87-94. PubMed ID: 3981817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor effect of Corynebacterium parvum].
    Mazurek C; Chalvet H; Biozzi G; Stiffel C
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corynebacterium parvum: effects on the biochemistry of mouse serum and liver.
    Green S; Dobrjansky A
    J Natl Cancer Inst; 1979 Aug; 63(2):497-502. PubMed ID: 379402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.